Liabilities / Assets
80th percentile
Higher debt load relative to assets than 80% of similar nonprofits.
Peptide Therapeutics Foundation
990EZ • Fiscal year 2017 • EIN 26-3728931
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.14x
Liabilities / Revenue
91st percentile
Higher debt load relative to revenue than 91% of similar nonprofits.
Net Margin
87th percentile
Higher net margin than 87% of similar nonprofits.
Top Officer Pay
76th percentile
Higher top officer pay than 76% of similar nonprofits.
Top officer pay equals 0.0% of source-year revenue.
Asset Growth
70th percentile
Faster asset growth than 70% of similar nonprofits.
Revenue Growth
77th percentile
Faster revenue growth than 77% of similar nonprofits.
Balance Sheet
Assets
Up$478,564
Up $74,215 (+18%) from 2016
Net Assets
Up$410,764
Up $65,035 (+19%) from 2016
Liabilities
Up$67,800
Up $9,180 (+16%) from 2016
Revenue And Expenses
Revenue
Up$172,574
Up $36,374 (+27%) from 2016
Expenses
Down$107,539
Down $14,087 (-12%) from 2016
Net Income
Up$65,035
Up $50,461 (+346%) from 2016
Historical Trend
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2017 to Dec 31, 2017
- Signed
- Mar 15, 2018
- Return Version
- 2017v2.2
- Gross Receipts
- $172,574
Mission and Program Overview
Mission
The mission of peptide therapeutics foundation is to provide and promote public and charitable educational and informational programs, materials, research and discussion in the medical scientific field of peptide science and technology.
Program Services
| Description | Grants | Expenses |
|---|---|---|
| HOLD A PEPTIDE THERAPEUTICS SYMPOSIUM TO BRING TOGETHER WORLD LEADERS FROM ACADEMIA, THE BIOPHARMACEUTICAL INDUSTRY, CMOS, CROS, AND INVESTORS INTERESTED IN ALL ASPECTS OF PEPTIDE R&D, INCLUDING DRUG DISCOVERY, SAFETY AND TOXICOLOGY, CLINICAL DEVELOMENT, MANUFACTURING, PHARMACEUTICAL DEVELOPMENT, FORMULATION, DRUG DELIVERY AND REGULATORY AFFAIRS. THE ORGANIZATION ALSO PROVIDED 13 POSTDOCTORAL FELLOWS AND GRADUATE STUDENTS WITH FREE REGISTRATION TO THE SYMPOSIUM. | - | $107,539 |
Compensation and Service Providers
Employees
| Name | Title | Full / Part Time | Base | Other | Total |
|---|---|---|---|---|---|
| MARIA BEDNAREK PHD | Fellow & Hea | - | $0 | - | - |
| RICHARD DIMARCHI PHD | Professor & | - | $0 | - | - |
| SOUMITRA GHOSH PHD | President | - | $0 | - | - |
| ANDREW PARKER | SVP & Chief | - | $0 | - | - |
| ALEKSANDER SWIETLOW | Global Direc | - | $0 | - | - |
| PANKAJ R PATEL | Chairman & D | - | $0 | - | - |
| CLAUDIO SCHTEINGART PHD | VP Science & | - | $0 | - | - |
| ADRIENNE DAY PHD | Bd.Sec. & Tr | - | $0 | - | - |
| GIRISH AAKALU | VP Of Scient | - | $0 | - | - |
| YVONNE ANGELL | Director Of | - | $0 | - | - |
| RAJV SHARMA | Representati | - | $0 | - | - |
Filing and Contact Details
Filer
- Filer Name
- Peptide Therapeutics Foundation
- EIN
- 26-3728931
- Phone
- 8586571511
- Address
- 4245 SORRENTO VALLEY BLVD, SAN DIEGO, CA 92121
Signing Officer
- Name
- Adrienne Day Phd
- Title
- Bd.sec. & Treasurer
- Phone
- 8586571511
- Signed
- 2018-03-15
Preparer
- Firm
- GOODSELL & COMPANY INC CPA'S
- Address
- 2665 4TH AVE, SAN DIEGO, CA 92103-6514
- Preparer
- Steven J Holc CPA
- Phone
- 6192384343
Supplemental Narrative
Additional Explanations
Form 990-ez, Part I, Line 16
“Expenses symposium expenses 103,539 foundation maintenance 1,019 board expenses 1,674 miscellaneous 47 total 106,279”
Form 990-ez, Part II, Line 26
“Accrued symposium expense 58,620 67,800”
Form 990-ez, Part III
“The mission of peptide therapeutics foundation is to provide and promote public and charitable educational and informational programs, materials, research and discussion in the medical scientific field of peptide science and technology.”
Form 990-ez, Part III, Line 28
“Hold a peptide therapeutics symposium to bring together world leaders from academia, the biopharmaceutical industry, cmos, cros, and investors interested in all aspects of peptide r&d, including drug discovery, safety and toxicology, clinical develoment, manufacturing, pharmaceutical development, formulation, drug delivery and regulatory affairs. The organization also provided 13 postdoctoral fellows and graduate students with free registration to the symposium.”
Raw XML Appendix181 raw XML fields
This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.
| Path | # | Value |
|---|---|---|
| IRS990EZ/ActivitiesNotPreviouslyRptInd | 0 | false |
| IRS990EZ/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt | 0 | THE ORGANIZATION |
| IRS990EZ/BooksInCareOfDetail/PhoneNum | 0 | 8586571511 |
| IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt | 0 | 4245 SORRENTO VALLEY BLVD |
| IRS990EZ/BooksInCareOfDetail/USAddress/CityNm | 0 | SAN DIEGO |
| IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd | 0 | CA |
| IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd | 0 | 92121 |
| IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt | 0 | 404349 |
| IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt | 0 | 478564 |
| IRS990EZ/ChgMadeToOrgnzngDocNotRptInd | 0 | false |
| IRS990EZ/ContributionsGiftsGrantsEtcAmt | 0 | 134940 |
| IRS990EZ/DonorAdvisedFndsInd | 0 | false |
| IRS990EZ/EngagedInExcessBenefitTransInd | 0 | false |
| IRS990EZ/ExcessOrDeficitForYearAmt | 0 | 65035 |
| IRS990EZ/FeesAndOtherPymtToIndCntrctAmt | 0 | 1260 |
| IRS990EZ/FiledScheduleAInd | 0 | true |
| IRS990EZ/ForeignFinancialAccountInd | 0 | false |
| IRS990EZ/ForeignOfficeInd | 0 | false |
| IRS990EZ/Form1120PolFiledInd | 0 | false |
| IRS990EZ/Form990TotalAssetsGrp/BOYAmt | 0 | 404349 |
| IRS990EZ/Form990TotalAssetsGrp/EOYAmt | 0 | 478564 |
| IRS990EZ/GrossReceiptsAmt | 0 | 172574 |
| IRS990EZ/InfoInScheduleOPartIIIInd | 0 | X |
| IRS990EZ/InfoInScheduleOPartIIInd | 0 | X |
| IRS990EZ/InfoInScheduleOPartIInd | 0 | X |
| IRS990EZ/LobbyingActivitiesInd | 0 | false |
| IRS990EZ/MadeLoansToFromOfficersInd | 0 | false |
| IRS990EZ/MethodOfAccountingAccrualInd | 0 | X |
| IRS990EZ/NetAssetsOrFundBalancesBOYAmt | 0 | 345729 |
| IRS990EZ/NetAssetsOrFundBalancesEOYAmt | 0 | 410764 |
| IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt | 0 | 345729 |
| IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt | 0 | 410764 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 0 | 0.25 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 1 | 0.25 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 2 | 0.25 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 3 | 0.25 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 4 | 0.25 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 5 | 0.25 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 6 | 0.25 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 7 | 2.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 8 | 0.25 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 9 | 0.25 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 10 | 0.25 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 0 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 1 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 2 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 3 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 4 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 5 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 6 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 7 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 8 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 9 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 10 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 0 | MARIA BEDNAREK PHD |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 1 | RICHARD DIMARCHI PHD |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 2 | SOUMITRA GHOSH PHD |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 3 | ANDREW PARKER |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 4 | ALEKSANDER SWIETLOW |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 5 | PANKAJ R PATEL |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 6 | CLAUDIO SCHTEINGART PHD |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 7 | ADRIENNE DAY PHD |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 8 | GIRISH AAKALU |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 9 | YVONNE ANGELL |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 10 | RAJV SHARMA |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 0 | FELLOW & HEA |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 1 | PROFESSOR & |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 2 | PRESIDENT |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 3 | SVP & CHIEF |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 4 | GLOBAL DIREC |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 5 | CHAIRMAN & D |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 6 | VP SCIENCE & |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 7 | BD.SEC. & TR |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 8 | VP OF SCIENT |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 9 | DIRECTOR OF |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 10 | REPRESENTATI |
| IRS990EZ/OperateHospitalInd | 0 | false |
| IRS990EZ/Organization501c3Ind | 0 | X |
| IRS990EZ/OrganizationDissolvedEtcInd | 0 | false |
| IRS990EZ/OrganizationHadUBIInd | 0 | false |
| IRS990EZ/OtherExpensesTotalAmt | 0 | 106279 |
| IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt | 0 | NONE |
| IRS990EZ/PartVIOfCompOfHghstPdEmplTxt | 0 | NONE |
| IRS990EZ/PoliticalCampaignActyInd | 0 | false |
| IRS990EZ/PrimaryExemptPurposeTxt | 0 | THE MISSION OF PEPTIDE THERAPEUTICS FOUNDATION IS TO PROVIDE AND PROMOTE PUBLIC AND CHARITABLE EDUCATIONAL AND INFORMATIONAL PROGRAMS, MATERIALS, RESEARCH AND DISCUSSION IN THE MEDICAL SCIENTIFIC FIELD OF PEPTIDE SCIENCE AND TECHNOLOGY. |
| IRS990EZ/ProgramServiceRevenueAmt | 0 | 37634 |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt | 0 | HOLD A PEPTIDE THERAPEUTICS SYMPOSIUM TO BRING TOGETHER WORLD LEADERS FROM ACADEMIA, THE BIOPHARMACEUTICAL INDUSTRY, CMOS, CROS, AND INVESTORS INTERESTED IN ALL ASPECTS OF PEPTIDE R&D, INCLUDING DRUG DISCOVERY, SAFETY AND TOXICOLOGY, CLINICAL DEVELOMENT, MANUFACTURING, PHARMACEUTICAL DEVELOPMENT, FORMULATION, DRUG DELIVERY AND REGULATORY AFFAIRS. THE ORGANIZATION ALSO PROVIDED 13 POSTDOCTORAL FELLOWS AND GRADUATE STUDENTS WITH FREE REGISTRATION TO THE SYMPOSIUM. |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt | 0 | 107539 |
| IRS990EZ/ProhibitedTaxShelterTransInd | 0 | false |
| IRS990EZ/RelatedOrganizationCtrlEntInd | 0 | false |
| IRS990EZ/SchoolOperatingInd | 0 | false |
| IRS990EZ/StatesWhereCopyOfReturnIsFldCd | 0 | CA |
| IRS990EZ/SubjectToProxyTaxInd | 0 | false |
| IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt | 0 | 58620 |
| IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt | 0 | 67800 |
| IRS990EZ/TanningServicesProvidedInd | 0 | false |
| IRS990EZ/TotalExpensesAmt | 0 | 107539 |
| IRS990EZ/TotalProgramServiceExpensesAmt | 0 | 107539 |
| IRS990EZ/TotalRevenueAmt | 0 | 172574 |
| IRS990EZ/TransactionWithControlEntInd | 0 | false |
| IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd | 0 | false |
| IRS990EZ/TypeOfOrganizationCorpInd | 0 | X |
| IRS990EZ/WebsiteAddressTxt | 0 | WWW.PEPTIDETHERAPEUTICS.ORG |
| IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt | 0 | OTHER INCOME 2,887 |
| IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc | 0 | PART III, LINE 12 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt | 0 | 134940 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt | 0 | 89940 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt | 0 | 104970 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt | 0 | 104940 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus4YearsAmt | 0 | 77440 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt | 0 | 512230 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearAmt | 0 | 37634 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus1YearAmt | 0 | 46260 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus2YearsAmt | 0 | 37788 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus3YearsAmt | 0 | 32735 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus4YearsAmt | 0 | 42876 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt | 0 | 197293 |
| IRS990ScheduleA/InvestmentIncomeCYPct | 0 | 0.00000 |
| IRS990ScheduleA/InvestmentIncomePYPct | 0 | 0.00000 |
| IRS990ScheduleA/OtherIncome509Grp/CurrentTaxYearAmt | 0 | 874 |
| IRS990ScheduleA/OtherIncome509Grp/CurrentTaxYearMinus4YearsAmt | 0 | 2013 |
| IRS990ScheduleA/OtherIncome509Grp/TotalAmt | 0 | 2887 |
| IRS990ScheduleA/PubliclySupportedOrg509a2Ind | 0 | X |
| IRS990ScheduleA/PublicSupportCY509Pct | 0 | 0.99590 |
| IRS990ScheduleA/PublicSupportPY509Pct | 0 | 0.99720 |
| IRS990ScheduleA/PublicSupportTotal509Amt | 0 | 709523 |
| IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind | 0 | X |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt | 0 | 172574 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt | 0 | 136200 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt | 0 | 142758 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt | 0 | 137675 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt | 0 | 120316 |
| IRS990ScheduleA/Total509Grp/TotalAmt | 0 | 709523 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt | 0 | 173448 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt | 0 | 136200 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt | 0 | 142758 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt | 0 | 137675 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt | 0 | 122329 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt | 0 | 712410 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 0 | EXPENSES SYMPOSIUM EXPENSES 103,539 FOUNDATION MAINTENANCE 1,019 BOARD EXPENSES 1,674 MISCELLANEOUS 47 TOTAL 106,279 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 1 | ACCRUED SYMPOSIUM EXPENSE 58,620 67,800 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 2 | THE MISSION OF PEPTIDE THERAPEUTICS FOUNDATION IS TO PROVIDE AND PROMOTE PUBLIC AND CHARITABLE EDUCATIONAL AND INFORMATIONAL PROGRAMS, MATERIALS, RESEARCH AND DISCUSSION IN THE MEDICAL SCIENTIFIC FIELD OF PEPTIDE SCIENCE AND TECHNOLOGY. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 3 | HOLD A PEPTIDE THERAPEUTICS SYMPOSIUM TO BRING TOGETHER WORLD LEADERS FROM ACADEMIA, THE BIOPHARMACEUTICAL INDUSTRY, CMOS, CROS, AND INVESTORS INTERESTED IN ALL ASPECTS OF PEPTIDE R&D, INCLUDING DRUG DISCOVERY, SAFETY AND TOXICOLOGY, CLINICAL DEVELOMENT, MANUFACTURING, PHARMACEUTICAL DEVELOPMENT, FORMULATION, DRUG DELIVERY AND REGULATORY AFFAIRS. THE ORGANIZATION ALSO PROVIDED 13 POSTDOCTORAL FELLOWS AND GRADUATE STUDENTS WITH FREE REGISTRATION TO THE SYMPOSIUM. |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 0 | FORM 990-EZ, PART I, LINE 16 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 1 | FORM 990-EZ, PART II, LINE 26 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 2 | FORM 990-EZ, PART III |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 3 | FORM 990-EZ, PART III, LINE 28 |
| ReturnHeader/BuildTS | 0 | 2018-06-14 16:35:46Z |
| ReturnHeader/BusinessOfficerGrp/PersonNm | 0 | ADRIENNE DAY PHD |
| ReturnHeader/BusinessOfficerGrp/PersonTitleTxt | 0 | BD.SEC. & TREASURER |
| ReturnHeader/BusinessOfficerGrp/PhoneNum | 0 | 8586571511 |
| ReturnHeader/BusinessOfficerGrp/SignatureDt | 0 | 2018-03-15 |
| ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt | 0 | PEPTIDE THERAPEUTICS FOUNDATION |
| ReturnHeader/Filer/BusinessNameControlTxt | 0 | PEPT |
| ReturnHeader/Filer/EIN | 0 | 263728931 |
| ReturnHeader/Filer/PhoneNum | 0 | 8586571511 |
| ReturnHeader/Filer/USAddress/AddressLine1Txt | 0 | 4245 SORRENTO VALLEY BLVD |
| ReturnHeader/Filer/USAddress/CityNm | 0 | SAN DIEGO |
| ReturnHeader/Filer/USAddress/StateAbbreviationCd | 0 | CA |
| ReturnHeader/Filer/USAddress/ZIPCd | 0 | 92121 |
| ReturnHeader/FilingSecurityInformation/AtSubmissionCreationDeviceId | 0 | 5D07FE3862598DFA09B2BC5D6C67A36B8BA055E7 |
| ReturnHeader/FilingSecurityInformation/AtSubmissionFilingDeviceId | 0 | 5D07FE3862598DFA09B2BC5D6C67A36B8BA055E7 |
| ReturnHeader/FilingSecurityInformation/FilingLicenseTypeCd | 0 | P |
| ReturnHeader/FilingSecurityInformation/IPAddress/IPv4AddressTxt | 0 | 98.171.214.221 |
| ReturnHeader/FilingSecurityInformation/IPDt | 0 | 2018-03-16 |
| ReturnHeader/FilingSecurityInformation/IPTimezoneCd | 0 | CD |
| ReturnHeader/FilingSecurityInformation/IPTm | 0 | 18:29:30 |
| ReturnHeader/PreparerFirmGrp/PreparerFirmEIN | 0 | 331005644 |
| ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt | 0 | GOODSELL & COMPANY INC CPA'S |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt | 0 | 2665 4TH AVE |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm | 0 | SAN DIEGO |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd | 0 | CA |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd | 0 | 921036514 |
| ReturnHeader/PreparerPersonGrp/PhoneNum | 0 | 6192384343 |
| ReturnHeader/PreparerPersonGrp/PreparationDt | 0 | 2018-03-16 |
| ReturnHeader/PreparerPersonGrp/PreparerPersonNm | 0 | STEVEN J HOLC CPA |
| ReturnHeader/ReturnTs | 0 | 2018-03-16T16:29:30-07:00 |
| ReturnHeader/ReturnTypeCd | 0 | 990EZ |
| ReturnHeader/TaxPeriodBeginDt | 0 | 2017-01-01 |
| ReturnHeader/TaxPeriodEndDt | 0 | 2017-12-31 |
| ReturnHeader/TaxYr | 0 | 2017 |
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2017 • Form 990EZDetailed filing. Detailed filing data is available for this year.
- Assets
- $478,564
- Liabilities
- $67,800
- Net assets
- $410,764
- Revenue
- $172,574
- Expenses
- $107,539
- Net income
- $65,035